 |
|
CODE
|
PROBE
|
ACC.N
|
MAP
|
UCSC May 2004
|
REMARKS
|
|
11A
|
RP11-412M16 |
AC093486 |
11p15.5 |
chr11:474,043-626,401
|
|
|
11B
|
RP11-401C19 |
AC083984 |
11p15.5 |
chr11:896,316-1,008,135
|
HLA4p&crosshyb. |
B-A |
|
|
|
|
|
HyA translocation |
|
3G
|
RP11-320O12 |
|
3p14.2 |
chr3:58,624,717-58,790,934
|
HLA4p&5q |
 |
|
RP11-380J21 |
AC092419 |
3p14.2 |
chr3:64,053,486-64,212,751
|
|
 |
3H
|
RP11-381G15 |
BES |
3p12.3 |
chr3:75,108,760-75,285,549
|
|
B-H |
|
|
|
|
|
|
 |
3A
|
RP11-183N22 |
AL512885 |
3p26.1 |
chr3:4,346,716-4,508,442
|
|
 |
|
RP11-586C12 |
BES |
3p25.2 |
chr3:12,371,879-12,557,693 |
|
 |
3B
|
RP11-1136I4 |
BES |
3p25.1 |
chr3:15,046,733-15,198,512
|
|
B-H
|
NLE
|
CH271-476O22 |
BES |
|
chr3:131,017,760/chr3:15,124,069 |
HLA4p |
CH271-120H2 |
BES |
|
chr3:131,030,663/chr3:15,124,079
|
|
3M
|
RP11-924M2 |
BES |
3q21.3 |
chr3:131,126,901-131,354,303
|
|
|
3L
|
RP11-60M4 |
BES |
3q13.3 |
chr3:122,646,524-122,832,137
|
|
|
3K
|
RP11-454H13 |
AC084198 |
3q12.3 |
chr3:102,798,693-103,006,891
|
|
|
|
HSA Centromere |
|
|
chr3:90,587,545-93,487,544
|
|
|
3J
|
RP11-655A17 |
AC107204 |
3p12.1 |
chr3:87,099,698-87,270,490
|
|
|
|
RP11-536K4 |
AC016942 |
3p12.3 |
chr3:76,682,896-76,834,909
|
|
|
3I
|
RP11-974E1 |
BES |
3p12.3 |
chr3:75,885,024-76,095,768
|
|
|
|
CENTROMERE |
|
|
|
|
B-L |
|
|
|
|
|
HLA fusion |
B-A |
|
|
|
|
|
HyA inversion |
|
13D
|
RP11-597B2
|
BES
|
13q14.11 |
chr13:38,988,139-39,162,449
|
HLA4q&4qtel |
|
13C
|
RP11-64I8
|
AL158065
|
13q12.3 |
chr13:30,502,889-30,571,189
|
|
 |
13B
|
RP11-780D7 |
BES |
13q12.3 |
chr13:26,335,941-26,501,574 |
|
B-N
|
NLE
|
CH271-423C2
|
BES
|
|
chr13:26,320,032/chr1:200,645,264
|
HLA4q&19p |
|
|
P11-953P22 |
BES |
13q12.2 |
chr13:26,135,827-26,354,020 |
|
 |
|
RP11-194P7 |
BES |
13q12.12 |
chr13:23,966,436-24,131,783 |
|
 |
13A
|
RP11-110K18
|
AL137119
|
13q11 |
chr13:19,404,215-19,568,080
|
|
B-A |
|
|
|
|
|
HyA inversion |
 |
13D
|
RP11-597B2
|
BES
|
13q14.11 |
chr13:38,988,139-39,162,449
|
HLA4q&4qtel |
 |
|
RP11-30N18 |
BES |
13q14.12 |
chr13:44,481,780-44,541,540
|
|
 |
13E
|
RP11-826G22 |
|
13q14.12 |
chr13:49,052,780-49,188,949 |
|
B-L |
|
|
|
|
|
HLA inversion |
 |
13I
|
RP11-691P11 |
BES |
13q33.1 |
chr13:101,988,634-102,149,936 |
HLA4q&4qtel |
 |
|
RP11-299K6 |
BES |
13q33.1 |
chr13:101,837,798-102,003,007
|
|
 |
13H
|
RP11-188A23 |
AL354831 |
13q22.3 |
chr13:77,153,157-77,297,742
|
|
 |
13G
|
RP11-10O23 |
AC013618 |
13q21.1 |
chr13:54,447,776-54,623,946
|
|
 |
13F
|
RP11-153K13 |
|
13q14.2 |
chr13:49,505,419-49,661,239
|
|
B-L |
|
|
|
|
|
HLA inversion |
|
13I
|
RP11-691P11 |
BES |
13q33.1 |
chr13:101,988,634-102,149,936 |
HLA4q&4qtel |
|
13J
|
RP11-245B11
|
AL161774
|
13q34 |
chr13:112,670,511-112,832,864
|
|
|